Korean J Psychopharmacol.  2008 May;19(3):163-167.

Use of Risperdal Consta during Pregnancy: Report of Four Cases with a Literature Review

Affiliations
  • 1Department of Psychiatry, Chonnam National University Medical School, Gwangju, Korea. jsyoon@chonnam.ac.kr
  • 2Clinical Trial Center, Chonnam National University Hospital, Gwangju, Korea.
  • 3Department of Psychiatry, St. John Hospital, Gwangju, Korea.

Abstract

Risperdal Consta is the first long-acting intramuscular formulation of an atypical antipsychotic. It is frequently used to treat schizophrenia, but its safety for use during pregnancy has not been established. We report four cases of patients with schizophrenia or schizoaffective disorder who took Risperdal Consta during pregnancy. None of the babies born from these four patients had any congenital malformation and all exhibited healthy postnatal development. This paper presents the rationale for the use of antipsychotics including Risperdal Consta during pregnancy and the related problems through a literature review. This serial case report contributes to the body of knowledge regarding the use of antipsychotics during pregnancy.

Keyword

Schizophrenia; Risperdal Consta; Pregnancy; Antipsychotic

MeSH Terms

Antipsychotic Agents
Humans
Pregnancy
Psychotic Disorders
Risperidone
Schizophrenia
Antipsychotic Agents
Risperidone
Full Text Links
  • KJP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr